Display Settings:

Format

Send to:

Choose Destination
    Herpes. 2009 Jan;15(3):62-3.

    Varicella zoster virus redux.

    Source

    Washington University School of Medicine, St Louis, MO 63110, USA. ldgelb@swbell.net

    Abstract

    In May 2008, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention in the USA recommended the routine administration of a live-attenuated high-potency varicella zoster vaccine to all adults over 60 years of age without specific contraindications, for the prevention and attenuation of herpes zoster (HZ). Nevertheless, many physicians still consider this vaccine to be of marginal value. This is not a reasonable conclusion. This short article reviews available data.

    PMID:
    19306605
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk